About Zim Laboratories Ltd
Zim Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Company has wholly owned subsidiaries (ZIM Laboratories FZE,UAE , SIA ZIM Laboratories Limited, Latvia, ZIM Health Technologies Limited, India and ZIM Thinorals Private Limited, India), subsidiary (ZIMTAS PTY Limited, Australia) and stepdown subsidiary (ZIM Scientific Office L.L.C,UAE (the Company and its subsidiaries are together referred to as 'the Group') which are engaged in manufacturing & wholesale of pharmaceutical products, market research and research & development activities.
Founded
1984
CEO
Anwar Daud
Employees
632
HQ
Nagpur, Maharashtra
Finished Products
1Sale of Manufactured Goods
₹1,714.46Cr2Sale of Traded Goods
₹65.77Cr3Export Incentives
₹22.34Cr4Product service income
₹19.92Cr5Out-Licensing Income
₹13.98Cr6Other Operating Revenue
₹0.67Cr7Others
₹0.47CrRaw Materials
1Raw Material Consumed
₹848.28Cr2DC Granules
₹10.51Cr3Pharmaceutical - Purchase
₹7.47Cr4Others
₹4.58Cr5Bulk Drugs
₹4.11Cr6Capsules-Purchased
₹0.14Cr7Tablets-Purchased
₹0.03CrAbout Zim Laboratories Ltd
Zim Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Company has wholly owned subsidiaries (ZIM Laboratories FZE,UAE , SIA ZIM Laboratories Limited, Latvia, ZIM Health Technologies Limited, India and ZIM Thinorals Private Limited, India), subsidiary (ZIMTAS PTY Limited, Australia) and stepdown subsidiary (ZIM Scientific Office L.L.C,UAE (the Company and its subsidiaries are together referred to as 'the Group') which are engaged in manufacturing & wholesale of pharmaceutical products, market research and research & development activities.
Founded:1984
CEO:Anwar Daud
Employees:632
HQ:Nagpur, Maharashtra
Finished Products
1Sale of Manufactured Goods
₹1,714.46Cr2Sale of Traded Goods
₹65.77Cr3Export Incentives
₹22.34Cr4Product service income
₹19.92Cr5Out-Licensing Income
₹13.98Cr6Other Operating Revenue
₹0.67Cr7Others
₹0.47CrRaw Materials
1Raw Material Consumed
₹848.28Cr2DC Granules
₹10.51Cr3Pharmaceutical - Purchase
₹7.47Cr4Others
₹4.58Cr5Bulk Drugs
₹4.11Cr6Capsules-Purchased
₹0.14Cr7Tablets-Purchased
₹0.03CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹137
52W Low
₹59
Volume680.39K
Avg VolumeN/A
Beta0.87
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
172.32x
Valuation
P/B Ratio
2.17x
Valuation
EPS
₹0.69
Valuation
Dividend Yield
0.00%
Valuation
ROE
1.97%
Profitability
ROCE
5.07%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
15.9%
International
84.1%
Outside India84.1%
In India15.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.42x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
0.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.